MedTrace Logo

Management of Soil-transmitted Helminthiasis and Strongyloidiasis

NCT01308268 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2000

Last updated 2011-03-04

No results posted yet for this study

Summary

The general purpose of the project is to analyse soil-transmitted helminthiases (STH) in a highly endemic area in northern Argentina with a multidisciplinary approach. The specific objectives are to evaluate the local epidemiology of STH, validate a new diagnostic serology method for S. stercoralis and evaluate the efficacy and safety of a mass drug administration regimen with albendazole and ivermectin.

Conditions

  • Helminthiasis
  • Strongyloides Stercoralis Infection

Interventions

DRUG

Ivermectin + Albendazole

Ivermectin: 200µg/kg, single dose, PO + Albendazole 200 (children between 12 and 23 months) or 400 mg (\>= 2 years old) single dose, PO

Sponsors & Collaborators

  • Fundación Mundo Sano

    collaborator UNKNOWN

  • Albert B. Sabin Vaccine Institute

    collaborator OTHER

  • Universidad Nacional de Salta

    lead OTHER

Principal Investigators

  • Alejandro Krolewiecki, MD, PhD · Universidad Nacional de Salta, Instituto de Investigación en Enfermedades Tropicales

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
1 Year
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-12-31
Primary Completion
2012-04-30
Completion
2012-04-30

Countries

  • Argentina

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01308268 on ClinicalTrials.gov